← Back to Clinical Trials
Recruiting Phase 3 NCT06241612

Individualized Elective Neck Irradiation in NPC Patients

Trial Parameters

Condition Nasopharyngeal Carcinoma
Sponsor Sun Yat-sen University
Study Type INTERVENTIONAL
Phase Phase 3
Enrollment 470
Sex ALL
Min Age 18 Years
Max Age 70 Years
Start Date 2024-04-16
Completion 2026-12-31
Interventions
Individualized Elective Neck Irradiation

Brief Summary

To evaluate whether individualized elective neck irradiation for nasopharyngeal carcinoma based on the vertebral level of metastatic lymph nodes can reduce the incidence of radiation-related adverse effects and improve patients' quality of life,without reducing survival.

Eligibility Criteria

Inclusion Criteria: * The eligibility criteria are: newly diagnosed, untreated, non-distant metastatic, and non-keratinizing NPC; nodes are diagnosed with PET/CT and MRI; staged as T1-4N0-2 or N3 category of non-bilateral lower-neck node metastasis; aged between 18 and 70 years; Karnofsky performance-status score \> 70; adequate haematological function, with a leucocyte count \> 4 × 109/L, haemoglobin \> 90 g/L, and a thrombocyte count \> 100×109/L Exclusion Criteria: * The exclusion criteria include: previous chemotherapy treatment, surgery (except diagnostic) or radiotherapy to the neck or nasopharyngeal regions; previous malignancy; lactation or pregnancy; or severe coexisting illness.

Related Trials